Patient presents with symptoms suggestive of prostatomegaly, including lower urinary tract symptoms (LUTS) such as urinary frequency, urgency, nocturia, hesitancy, weak stream, straining to void, and incomplete emptying.  Digital rectal exam (DRE) revealed an enlarged prostate, estimated to be [size] grams, with [consistency; e.g., smooth, firm, nodular] texture.  Differential diagnosis includes benign prostatic hyperplasia (BPH), prostate cancer, and prostatitis.  Patient denies fever, chills, or perineal pain, making infectious prostatitis less likely.  Prostate-specific antigen (PSA) level was [PSA value] ngml.  Based on the patient's presentation, benign prostatic hyperplasia (BPH) is the suspected primary diagnosis.  The International Prostate Symptom Score (IPSS) was administered, and the patient scored [IPSS score], indicating [severity of symptoms; e.g., mild, moderate, severe] LUTS.  Treatment options discussed include watchful waiting, lifestyle modifications (including fluid management and dietary changes), medical therapy with alpha-blockers or 5-alpha reductase inhibitors, and surgical interventions such as transurethral resection of the prostate (TURP) or minimally invasive procedures.  Patient education provided regarding the natural history of BPH, potential complications, and the benefits and risks of various treatment modalities.  Follow-up scheduled in [duration] to reassess symptoms and consider further diagnostic testing if indicated, such as uroflowmetry, post-void residual measurement, and or transrectal ultrasound of the prostate.  ICD-10 code N40.1 (benign prostatic hyperplasia) and CPT codes for the evaluation and management (E/M) service provided, including the DRE (e.g., 99202-99215), and any additional procedures, such as the PSA test (84153), will be documented for medical billing and coding purposes.